Feature|Videos|January 9, 2025
Reflecting on the COVID-19 Pandemic Response
Lessons from the COVID-19 response highlight regulatory collaboration, research expansion, and challenges in vaccine access and preparedness.
Advertisement
Episodes in this series
A lot can be learned from the COVID-19 response, including global regulatory collaboration, de-risking pharmaceutical development, and expanding research participation. This segment covers challenges such as sustaining preparedness and addressing vaccine access inequities.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5